Send to

Choose Destination
Int J Antimicrob Agents. 2002 Sep;20(3):220-2.

Activity of GAR-936 and other antimicrobial agents against North American isolates of Staphylococcus aureus.

Author information

Department of Microbiology, Toronto Medical Laboratories, Mount Sinai Hospital, Room 1487, 600 University Avenue, Toronoto, Ont, Canada M5G 1X5.


The comparative in vitro activity of GAR-936 and 12 other drugs against 602 North American isolates of methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus was determined. The GAR-936 MICs ranged from 0.06 to 1.0 mg/l. The MIC(50)s and MIC(90)s were 0.12 and 0.25 mg/l for MSSA and 0.25 and 0.5 mg/l for MRSA.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center